Kangmei Pharma | 600518 - Debt



Kangmei Pharma reported CNY215.93M in Debt for its fiscal quarter ending in September of 2024.

Debt Change Date
Alaunos Therapeutics USD 0 0 Jun/2024
Avita Medical AUD 45.09M 354K Jun/2024
Cspc Pharmaceutical CNY 388.87M 318.03M Jun/2024
Dianthus Therapeutics USD 0 407K Sep/2024
Genomma Lab Internacional MXN 6.59B 215.42M Sep/2024
Hypermarcas BRL 10.2B 413.61M Jun/2024
Ionis Pharmaceuticals USD 1.28B 164.95M Sep/2024
IQVIA Holdings USD 13.51B 62M Sep/2024
Jiangsu Hengrui CNY 87.58M 7.44M Sep/2024
Kangmei Pharma CNY 215.93M 40.04M Sep/2024
Moderna USD 625M 644M Sep/2024
Organon & Co USD 8.75B 93M Sep/2024
Revvity USD 3.19B 810.4M Sep/2024
Sh Fosun Pharma CNY 35.59B 797.78M Sep/2024
Tectonic Therapeutic USD 1.11M 887K Jun/2024
Viatris USD 15.75B 1.63B Sep/2024
Wuxi Apptec CNY 7.09B 1.35B Mar/2024
Xeris Pharmaceuticals USD 231.28M 38.52M Sep/2024
Zz Pientze Pharmaceu 1.18B 28.21M Sep/2024